Risk analysis of regorafenib related hepatobiliary system injury based on the US Food and Drug Administration Adverse Event Reporting System

Long Xia, Zeng Xiaohuan, Gan Xiaohong

PDF(370 KB)
PDF(370 KB)
Adverse Drug Reactions Journal ›› 2020, Vol. 22 ›› Issue (4) : 227-232. DOI: 10.3760/cma.j.cn114015-20190615-00491

Risk analysis of regorafenib related hepatobiliary system injury based on the US Food and Drug Administration Adverse Event Reporting System

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2020, 22(4): 227-232 https://doi.org/10.3760/cma.j.cn114015-20190615-00491

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(370 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉